Nicolae Leca

Nicolae Leca practices at UW Medical Center - Montlake in Seattle, Washington, part of University of Washington.

Nicolae Leca's NPI, 1407931215, was assigned on October 27, 2006. Nicolae Leca holds Washington license MD00045108.

Nicolae Leca's primary practice is UW Medical Center - Montlake, at 1959 NE Pacific St Box 356151, Seattle, WA 98195 in King County. The practice phone is (206) 598-3300.

Nicolae Leca's primary practice is UW Medical Center - Montlake in Seattle, Washington, part of University of Washington. Nicolae Leca is also affiliated with MultiCare Tacoma General Hospital. The medical group on file is UW Physicians. Dmand AI also links Nicolae Leca to 4 more hospitals, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Nicolae Leca practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Nicolae Leca's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Nicolae Leca is licensed in Washington.

CMS data shows 669 Medicare services from Nicolae Leca across 6 procedure codes in 2024, for 161 Medicare patients. Medicare paid $53,038 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 161 Medicare patients who saw Nicolae Leca in 2024. The largest group is under 65, with 72 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 25% are also on Medicaid. Their average risk score is 5.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Nicolae Leca's median patient age at 54, with 49% women.

In 2024, Nicolae Leca wrote 1,305 Medicare Part D claims for 97 patients. 93% of them were for generic drugs. CMS names the drug for 1,119 of them, across 28 drugs with 11 or more claims each, at $89,213 in total drug cost. In 2023, CMS named 869 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Nicolae Leca for performance year 2024, reported through an alternative payment model (APM). Nicolae Leca accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Nicolae Leca as offering telehealth.

Dmand AI links 52 papers to Nicolae Leca, published from 2011 to 2025. 2023 was the busiest year, with 8. The most frequent topics are Kidney Transplantation, Graft Survival and Graft Rejection. Nicolae Leca has published most often in Transplant Proc. Nicolae Leca's most frequent co-authors are Lena Sibulesky, MD, James D. Perkins and Ramasamy Bakthavatsalam.

Dmand AI links Nicolae Leca to 2 clinical trials. 1 is still active or recruiting.

CMS Open Payments shows 128 general payments to Nicolae Leca from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 78% of the total. Travere Therapeutics, Inc. paid the most, $22,421.